Executive Director, Global Forecasting

Revolution Medicines
•$252,000 - $315,000•Onsite

About The Position

Revolution Medicines is a global oncology company focused on discovering, developing and delivering medicines for patients with RAS-addicted cancers. The Executive Director, Global Forecasting leads the global forecasting function across disease areas and the portfolio, covering assets from preclinical and Phase 1 development through commercialization. Reporting to the Vice President, Global Analytics & Insights, this leader directly manages three Senior Directors and builds the teams and capabilities needed to support an expanding portfolio. The role integrates forecasts and scenarios into a coherent view of opportunity, demand and risk to inform development, lifecycle, investment and commercial decisions. In partnership with global and regional teams, the Executive Director establishes shared forecasting standards, aligns priorities and translates uncertainty into clear recommendations for senior leadership. The position is based at Revolution Medicines’ headquarters in Redwood City, California, with domestic and international travel as needed, typically up to 25–30%. The company describes its people as guided by scientific rigor, challenging assumptions, urgency and high standards in service of patients. Its total rewards program includes competitive cash compensation, equity awards, benefits, and learning and development opportunities. The listed onsite base salary range is $252,000–$315,000, adjusted for the local market and determined in part by skills, experience, market dynamics, education and training.

Requirements

  • Bachelor’s degree.
  • 15+ years of progressive experience in biotechnology, pharmaceuticals or consulting, including substantial experience leading forecasting in oncology.
  • Experience managing senior leaders and managers, developing teams and scaling forecasting capabilities in a growing organization.
  • Deep expertise in patient-based forecasting, portfolio scenarios and risk analysis across early development, launch and commercial stages, including interactions among multiple products and indications.
  • Experience translating forecasts into long-range plans, supply requirements, portfolio investment decisions and business opportunity assessments.
  • Experience establishing shared methods, governance and systems across global and regional teams while accommodating justified market differences.
  • Strong analytical judgment and business acumen, including the ability to challenge assumptions, communicate uncertainty, and influence senior leadership and cross-functional partners.
  • Ability to prioritize competing needs, work effectively through ambiguity, and combine functional leadership with direct contributions to critical business questions.

Nice To Haves

  • Advanced degree in a quantitative, scientific or business discipline.
  • Experience launching targeted oncology therapies globally and supporting business development or commercialization partnerships.
  • Experience applying advanced analytics and probabilistic methods to portfolio forecasting and decision making.

Responsibilities

  • Set global forecasting strategy, operating model and priorities across early products, later-stage programs and commercial assets, aligning resources and delivery with business decisions and planning cycles.
  • Manage, coach and develop three Senior Directors and their teams; establish accountabilities across disease-area forecasting and portfolio methods, systems and analytics; build leadership capacity; and manage functional budgets and vendors.
  • Oversee global patient-based, revenue and demand forecasts, integrating regional inputs into a consistent portfolio view and agreeing forecast ownership, review and approval with regional leaders, Finance and Supply Chain.
  • Challenge forecast assumptions and ensure analytical rigor, transparent regional perspectives and clear documentation of unresolved differences.
  • Lead forecasting contributions to cross-portfolio scenario planning with Disease Area Insights and Data & Analytics, assessing overlapping populations, treatment sequencing, combinations, launch timing and product interactions to quantify incremental opportunity and avoid double counting.
  • Establish shared global and regional frameworks for methodologies, core assumptions, scenarios, documentation and review, while providing an agreed process for justified local adaptations.
  • Oversee forecasting model design, methodologies, consolidation logic and analytical requirements; partner with Data & Analytics and Information Systems on shared data infrastructure and platform delivery; and guide adoption of probabilistic methods, sensitivity analyses and decision frameworks where useful.
  • Partner with Finance and Supply Chain on forecasts and scenarios for long-range plans, budgets, launch readiness, supply and capacity planning, and ongoing commercial and demand planning.
  • Ensure transparent translation of patient, treatment-duration and utilization assumptions into revenue and demand, with clear bridges between strategic, operating and supply-planning views.
  • Lead forecasting for early product assessments, development and lifecycle options, portfolio prioritization and go/no-go decisions; quantify scenarios and value drivers; and contribute to integrated Analytics & Insights recommendations.
  • Support Business and Corporate Development and Commercial Partnerships with business cases, scenarios and independent assessment of assumptions.
  • Partner with Disease Area Insights, Data & Analytics, Commercial, Clinical Development, Medical Affairs, Market Access and Portfolio Strategy to incorporate evidence, competitive developments and market dynamics into forecasts and strategic recommendations.
  • Coordinate with regional forecasting leaders on priorities, ownership, support and transitions based on local capabilities and needs; strengthen local capabilities and facilitate reuse of tools and effective practices.
  • Agree capacity, service expectations and readiness criteria for regional transitions while maintaining continuity of support.
  • Establish forecast review and quality-assurance processes, including model validation, version control, assumption traceability and analysis of forecast changes.
  • Use actual performance and emerging evidence to improve forecasts, evaluate accuracy and bias at appropriate horizons, and explain their drivers.
  • Present integrated forecasts, ranges, risks and strategic implications to senior leadership; resolve cross-functional differences where possible and elevate material tradeoffs and unresolved assumptions for decisions.
  • Travel domestically and internationally as needed, typically up to 25–30%.

Benefits

  • Competitive cash compensation
  • Equity awards
  • Strong benefits
  • Learning and development opportunities
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service